Love Pharma Inc. filed its Annual on May 01, 2023 for the period ending Dec 31, 2022. In this report its auditor, Baker Tilly WM LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Apr. 30 | Jolt Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 27 | Jolt Health Inc. announced that it has received CAD 0.5 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 466K | |
+31.81% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.23% | 239B | |
+9.93% | 210B | |
-7.20% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- JOLT Stock
- News Jolt Health Inc.
- Love Pharma Inc. Auditor Raises 'Going Concern' Doubt